Comparison of Serum Level of Antiphospholipid Antibodies and Homocysteine in Patients with Pemphigus Vulgaris and Healthy Subjects
暂无分享,去创建一个
[1] G. Di Minno,et al. Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] M. Ciaccio,et al. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction. , 2010, Current clinical pharmacology.
[3] D. Fanoni,et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications , 2009, The British journal of dermatology.
[4] D. Zillikens,et al. Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-Mediated Transinteraction1 , 2008, The Journal of Immunology.
[5] P. Lazzerini,et al. Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases? , 2007, Lupus.
[6] M. Inaoki,et al. Antiphospholipid antibodies in patients with autoimmune blistering disease. , 2007, Journal of the American Academy of Dermatology.
[7] P. Lazzerini,et al. Hyperhomocysteinemia, inflammation and autoimmunity. , 2007, Autoimmunity reviews.
[8] T. van der Poll,et al. Two-way interactions between inflammation and coagulation. , 2005, Trends in cardiovascular medicine.
[9] S. Lentz. Mechanisms of homocysteine‐induced atherothrombosis , 2005, Journal of thrombosis and haemostasis : JTH.
[10] C. Kallenberg,et al. Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.
[11] Y. Shoenfeld,et al. Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome. , 2001, Rheumatic diseases clinics of North America.
[12] W. Petritsch,et al. Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease , 1999, Digestive Diseases and Sciences.
[13] T. Barbui,et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. , 1996, The American journal of medicine.
[14] O. Vaarala,et al. Antibodies to Prothrombin Imply a Risk of Myocardial Infarction in Middle-Aged Men , 1996, Thrombosis and Haemostasis.
[15] I. Scharrer,et al. Criteria for the Diagnosis of Lupus Anticoagulants: An Update , 1995, Thrombosis and Haemostasis.
[16] A. Amoroso,et al. Anti‐cardiolipin antibodies in autoimmune thyroid diseases , 1994, Clinical endocrinology.
[17] M. Aiach,et al. [Evaluation of hemostasis in venous thromboembolism pathology]. , 1998, Annales de biologie clinique.
[18] E. Harris,et al. The antiphospholipid syndrome , 1995, Clinical reviews in allergy & immunology.
[19] W. Matzner,et al. Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. , 1994, The Journal of reproductive medicine.
[20] J. Stanley. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. , 1993, Advances in immunology.
[21] B. Vester,et al. High Performance Liquid Chromatography Method for Rapid and Accurate Determination of Homocysteine in Plasma and Serum , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.